Oct 2026
An α1D-adrenergic receptor vaccine protects against HFpEF in mice.
AIMS Heart failure with preserved ejection fraction (HFpEF) remains a global clinical challenge with high mortality and restricted therapeutic options. Persistent sympathetic nervous system (SNS) overactivation, systemic metabolic dysregulation, and chronic inflammation are hallmarks of HFpEF pathogenesis. We developed...
Jia-Cheng Wu, Ding Shi, Yi-Yi Wang et al.
· International Immunopharmaco... · 0 citations